Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG). (Record no. 24870894)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02273 a2200625 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517031610.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201601s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1471-2407 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1186/s12885-015-1323-9 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Huiskens, Joost |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20160128 |
245 00 - TITLE STATEMENT | |
Title | Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG). |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | BMC cancer |
Date of publication, distribution, etc. | May 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 365 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bevacizumab |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Camptothecin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Colorectal Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fluorouracil |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leucovorin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Liver Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoadjuvant Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Organoplatinum Compounds |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Panitumumab |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Gulik, Thomas M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Lienden, Krijn P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Engelbrecht, Marc R W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Meijer, Gerrit A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Grieken, Nicole C T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schriek, Jonne |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Keijser, Astrid |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mol, Linda |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Molenaar, I Quintus |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Verhoef, Cornelis |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | de Jong, Koert P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dejong, Kees H C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kazemier, Geert |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ruers, Theo M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | de Wilt, Johanus H W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Tinteren, Harm |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Punt, Cornelis J A |
773 0# - HOST ITEM ENTRY | |
Title | BMC cancer |
Related parts | vol. 15 |
-- | p. 365 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1186/s12885-015-1323-9">https://doi.org/10.1186/s12885-015-1323-9</a> |
Public note | Available from publisher's website |
No items available.